HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Komninou, D. Articles by Rigas, B. Search for Related Content PubMed PubMed Citation Articles by Komninou, D. Articles by Rigas, B.

---

MINIREVIEW

Insulin Resistance and Its Contribution to Colon Carcinogenesis

Despina Komninou^*, Alexis Ayonote, John P. Richie, Jr.^* and Basil Rigas^*,,1

^* American Health Foundation and
Sarah C. Upham Division of Gastroenterology, New York Medical College, Valhalla, New York 10595

The insulin resistance-colon cancer hypothesis, stating that insulin resistance may be associated with the development of colorectal cancer, represents a significant advance in colon cancer, as it emphasizes the potential for this cancer to become a modifiable disease. The fact that the incidence of insulin resistance has been increasing in the United States and much of the rest of the Western world where colon cancer remains the second leading cause of cancer death makes the exploration of the interrelationship of these conditions a subject of high priority. Here, we review the salient features of insulin resistance, defined as impaired biological response to the action of insulin. Recent epidemiological studies, evaluating potential associations between colon cancer risk and diabetes mellitus, dietary intake and metabolic factors, and IGF levels in several clinical settings, provide strong support of the insulin resistance-colon cancer hypothesis (without establishing causality). Mechanistically, insulin resistance has been associated with hyperinsulinemia, increased levels of growth factors including IGF-1, and alterations in NF-B and peroxisome proliferator-activated receptor signaling, which may promote colon cancer through their effects on colonocyte kinetics. It is a reasonable expectation that in the not too distant future, critical interventions to the already mapped molecular sequence of events, which link two apparently disparate entities, combined with lifestyle changes could abrogate the development of colon cancer.

Key Words: insulin resistance • colon cancer • carcinogenesis • IGF-1 • aging

This article has been cited by other articles:

				H-L Wong, W-P Koh, N M Probst-Hensch, D Van den Berg, M C Yu, and S A Ingles Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach Gut, August 1, 2008; 57(8): 1090 - 1096. [Abstract] [Full Text] [PDF]

				R. L. Sedjo, T. Byers, T. R. Levin, S. M. Haffner, M. F. Saad, J. A. Tooze, and R. B. D'Agostino Jr. Change in Body Size and the Risk of Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 526 - 531. [Abstract] [Full Text] [PDF]

				C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]

				K. Bowers, D. Albanes, P. Limburg, P. Pietinen, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon A Prospective Study of Anthropometric and Clinical Measurements Associated with Insulin Resistance Syndrome and Colorectal Cancer in Male Smokers Am. J. Epidemiol., October 1, 2006; 164(7): 652 - 664. [Abstract] [Full Text] [PDF]

				G. He, Y. M. Sung, J. DiGiovanni, and S. M. Fischer Thiazolidinediones Inhibit Insulin-Like Growth Factor-I-Induced Activation of p70S6 Kinase and Suppress Insulin-Like Growth Factor-I Tumor-Promoting Activity Cancer Res., February 1, 2006; 66(3): 1873 - 1878. [Abstract] [Full Text] [PDF]

				A. Seow, J.-M. Yuan, W.-P. Koh, H.-P. Lee, and M. C. Yu Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study J Natl Cancer Inst, January 18, 2006; 98(2): 135 - 138. [Abstract] [Full Text] [PDF]

				T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081. [Abstract] [Full Text] [PDF]

				J. I. Fenton, N. G. Hord, J. A. Lavigne, S. N. Perkins, and S. D. Hursting Leptin, Insulin-Like Growth Factor-1, and Insulin-Like Growth Factor-2 Are Mitogens in ApcMin/+ but not Apc+/+ Colonic Epithelial Cell Lines Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1646 - 1652. [Abstract] [Full Text] [PDF]

				Z. Gong, D. Xie, Z. Deng, R. M. Bostick, S. J. Muga, T. G. Hurley, and J. R. Hebert The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas Carcinogenesis, March 1, 2005; 26(3): 579 - 585. [Abstract] [Full Text] [PDF]

				C. K. Roberts and R. J. Barnard Effects of exercise and diet on chronic disease J Appl Physiol, January 1, 2005; 98(1): 3 - 30. [Abstract] [Full Text] [PDF]

				R. J. Barnard Prevention of Cancer Through Lifestyle Changes Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 233 - 239. [Abstract] [Full Text] [PDF]

				D. B. Boyd Insulin and Cancer Integr Cancer Ther, December 1, 2003; 2(4): 315 - 329. [Abstract] [PDF]

				B. T. Larson, D. F. Lawler, E. L. Spitznagel Jr, and R. D. Kealy Improved Glucose Tolerance with Lifetime Diet Restriction Favorably Affects Disease and Survival in Dogs J. Nutr., September 1, 2003; 133(9): 2887 - 2892. [Abstract] [Full Text] [PDF]